Detecting cancer early remains an underutilized driver of successful treatment outcomes. Cancer has one of the highest incidence rates and is the leading cause of cancer-related deaths in the United States (U.S.), with over 228,000 cases diagnosed annually. Unfortunately, many patients are not diagnosed until the disease has progressed, resulting in a 5-year survival rate of less than 28%. The U.S. Preventative Services Task Force recommends annual screening, however, not every eligible individual receive screening due to various factors, including lack of awareness, prohibitively high costs, and limited access. This means that more than 30 million Americans are not receiving the necessary screening to help catch the disease early at a more curable stage. The current standard of care for cancer screening is often invasive and has low accuracy which leads to unnecessary follow-up diagnostic testing and anxiety that further exacerbate the fear of getting screened.

U.S. Cancer Statistics

In 2023, roughly 2.0 million people will be diagnosed with cancer in the United States.

An estimated 297,790 women and 2,800 men will be diagnosed with breast cancer, which makes it the most common cancer diagnosis. Prostate cancer is the leading cancer diagnosis among men and the second most common diagnosis overall with 288,300 expected cases. Lung and bronchus cancer is the third most common cancer diagnosis with an estimated 238,340 new cases.

Source: SEER, NCI

In 2023, an estimated 609,820 people will die of cancer in the United States.

Lung and bronchus cancer is responsible for the most deaths with 127,070 people expected to die from this disease. That is nearly three times the 52,550 deaths due to colorectal cancer, which is the second most common cause of cancer death.

Source: SEER, NCI

The relative 5-year cancer survivability rate varies greatly between cancers.

Prostate cancer has the highest five-year overall survivability rate at 97.1%. The five-year overall survivability rate for breast cancer is 90.7%, followed by colorectal cancer at 65%. Lung cancer has the lowest survivability rate at 25.4%.

Source: SEER, NCI